Kategorien
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
19-Norandrostene-3,17-dione
(59378954 | 734-32-7)
CAS: | 734-32-7 |
---|---|
Molekularformel: | C18H24O2 |
Molekulargewicht: | 272.4 |
Verfügbarkeit: | Auf Lager |
---|---|
Downloads: |
Für dieses Produkt wird ein Gefahrstoffzuschlag erhoben. Der genaue Betrag wird von unserem Verkaufsteam bestätigt.
59378954-1g | 1g | £171.00 | |
Bulk Menge |
59378954-1g | 1g | €239.40 | |
Bulk Menge |
59378954-1g | 1g | $256.50 | |
Bulk Menge |
Spezifikation
Analysezertifikat
Produktbeschreibung
Product Code | 59378954 | ||||
Product Name | 19-Norandrostene-3,17-dione | ||||
Categories | Bioactive Small Molecules Biochemicals Research Organics & Inorganics | ||||
CAS | 734-32-7 | ||||
Molecular Formula | C18H24O2 | ||||
Molecular Weight | 272.4 | ||||
Storage Details | -15 to -20 °C | ||||
Harmonised Tariff Code | 29372900 |
Produktspezifikation
Melting Point | 163 - 173 Deg C | ||||
Heavy metals | <10ppm | ||||
Single Impurity | <0.5% | ||||
Loss on Drying | <0.5% | ||||
Assay (HPLC) | >99% | ||||
Total Impurities | <1.0% | ||||
Appearance | White crystalline powder |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|